Literature DB >> 24392315

Essential concept of transplant immunology for clinical practice.

Damodar Kumbala1, Rubin Zhang1.   

Abstract

Our understanding of transplant immunology has advanced from gross allograft rejection to cellular response and to current molecular level. More sensitive assays have been developed to characterize patient sensitization and to detect pre-existing donor-specific antibodies (DSA) in pre-transplant crossmatch. After a transplant, pre-existing or de novo DSA are increasingly monitored to guide clinical management. Therefore, it is important for clinicians to understand the basic concepts and key components of transplant immunology as well as be familiarized with the modern immunological techniques used in kidney transplantation.

Entities:  

Keywords:  Alloimmune response; Co-stimulation pathway; Crossmatch; Donor specific antibody; Human leukocyte antigens; Major histocompatibility complex; Non-human leukocyte antigens antibody; Panel reactive antibody

Year:  2013        PMID: 24392315      PMCID: PMC3879520          DOI: 10.5500/wjt.v3.i4.113

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  28 in total

Review 1.  Memory T cells: a hurdle to immunologic tolerance.

Authors:  Fadi G Lakkis; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

Authors:  Christian P Larsen; Thomas C Pearson; Andrew B Adams; Paul Tso; Nozomu Shirasugi; Elizabeth Strobert; Dan Anderson; Shannon Cowan; Karen Price; Joseph Naemura; John Emswiler; JoAnne Greene; Lori Ann Turk; Jurgen Bajorath; Robert Townsend; David Hagerty; Peter S Linsley; Robert J Peach
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

4.  Long-term outcome of highly sensitized African American patients transplanted with deceased donor kidneys.

Authors:  Qing Ren; Anil Paramesh; C Lillian Yau; Mary Killackey; Douglas Slakey; Sandy Florman; Joseph Buell; Brent Alper; Eric Simon; L Lee Hamm; Rubin Zhang
Journal:  Transpl Int       Date:  2010-11-22       Impact factor: 3.782

Review 5.  Why do some females reject males? The molecular basis for male-specific graft rejection.

Authors:  D M Scott; I E Ehrmann; P S Ellis; P R Chandler; E Simpson
Journal:  J Mol Med (Berl)       Date:  1997-02       Impact factor: 4.599

6.  MIC expression in renal and pancreatic allografts.

Authors:  Kim G Hankey; Cinthia B Drachenberg; John C Papadimitriou; David K Klassen; Benjamin Philosophe; Steven T Bartlett; Veronika Groh; Thomas Spies; Dean L Mann
Journal:  Transplantation       Date:  2002-01-27       Impact factor: 4.939

7.  Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

Authors:  Duska Dragun; Dominik N Müller; Jan Hinrich Bräsen; Lutz Fritsche; Melina Nieminen-Kelhä; Ralf Dechend; Ulrich Kintscher; Birgit Rudolph; Johan Hoebeke; Diana Eckert; Istvan Mazak; Ralph Plehm; Constanze Schönemann; Thomas Unger; Klemens Budde; Hans-Hellmut Neumayer; Friedrich C Luft; Gerd Wallukat
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

Review 8.  Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols.

Authors:  R A Montgomery
Journal:  Am J Transplant       Date:  2010-02-01       Impact factor: 8.086

9.  Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Authors:  Ashley A Vo; Marina Lukovsky; Mieko Toyoda; Jennifer Wang; Nancy L Reinsmoen; Chih-Hung Lai; Alice Peng; Rafael Villicana; Stanley C Jordan
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

Review 10.  Regulation of B-cell entry into the cell cycle.

Authors:  Sabrina Richards; Chie Watanabe; Lorna Santos; Andrew Craxton; Edward A Clark
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  6 in total

Review 1.  Donor-Specific Antibodies in Kidney Transplant Recipients.

Authors:  Rubin Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-26       Impact factor: 8.237

Review 2.  Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Authors:  Valeria R Mas; Thu H Le; Daniel G Maluf
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

3.  A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.

Authors:  Afia Umber; Mary Killackey; Anil Paramesh; Yongjun Liu; Huaizhen Qin; Muhammad Atiq; Belinda Lee; Arnold Brent Alper; Eric Simon; Joseph Buell; Rubin Zhang
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

4.  Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection.

Authors:  Clara Fischman; Miguel Fribourg; Ginevri Fabrizio; Michela Cioni; Patrizia Comoli; Arcangelo Nocera; Massimo Cardillo; Chiara Cantarelli; Lorenzo Gallon; Astgik Petrosyan; Stefano Da Sacco; Laura Perin; Paolo Cravedi
Journal:  Transplant Direct       Date:  2019-08-08

5.  The natural history of de novo donor-specific HLA antibodies after kidney transplantation.

Authors:  Covadonga López Del Moral; Kaiyin Wu; Marcel Naik; Bilgin Osmanodja; Aylin Akifova; Nils Lachmann; Diana Stauch; Sabine Hergovits; Mira Choi; Friederike Bachmann; Fabian Halleck; Eva Schrezenmeier; Danilo Schmidt; Klemens Budde
Journal:  Front Med (Lausanne)       Date:  2022-09-16

Review 6.  Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.

Authors:  Tilahun Alelign; Momina M Ahmed; Kidist Bobosha; Yewondwossen Tadesse; Rawleigh Howe; Beyene Petros
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.